One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Tempus AI cleared that benchmark Thursday, with a jump from 80 to 84 Thursday.
Risk Management In The Stock Market: How Much Money To Invest Now
IBD's unique RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the last 52 weeks matches up against the rest of the market.
Decades of market research reveals that the stocks that go on to make the biggest gains typically have an 80 or better RS Rating as they launch their biggest price moves.
Tempus AI is working on a consolidation with a 74.83 entry. See if it can clear the breakout price in heavy trade.
Tempus AI showed 0% EPS growth in its most recent report, while sales growth came in at 75%. Look for the next report on or around Aug. 8.
The company earns the No. 13 rank among its peers in the Medical-Research Equipment/Services industry group. Medpace Holdings, IQVIA Holdings and Charles River Labs Intl are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
